The global synthetic opioids market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of opioid-related deaths and addiction cases in North America, Europe, and Asia Pacific. The pain management application segment is expected to dominate the global synthetic opioids market during the forecast period due to its high demand for pain relief medication. Methadone dominated the global synthetic opioids market in 2017 with a share of over 50%. Fentanyl was second with a share of around 30%. Meperidine accounted for around 10% while hydrocodone accounted for less than 10%. Oxymorphone accounted for less than 5% while oxycodone accounted for less than 1%.
Some Of The Growth Factors Of This Market:
- The increase in the number of people who are addicted to opioids.
- The increase in the number of people who are addicted to heroin.
- The increase in the number of people who are addicted to prescription drugs.
- The decrease in the cost of synthetic opioids on the black market.
- The lack of awareness about synthetic opioids.
Industry Growth Insights published a new data on “Synthetic Opioids Market”. The research report is titled “Synthetic Opioids Market research by Types (Methadone, Fentanyl, Meperidine, Hydrocodone, Oxymorphone, Oxycodone), By Applications (Pain Management, De-addiction), By Players/Companies Purdue Pharma, Pfizer, Janssen Pharmaceuticals, Teva Pharmaceuticals, Endo International, West-Ward Pharmaceuticals, Mallinckrodt Pharmaceuticals, Mylan, Impax Laboratories, Indivior”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Synthetic Opioids Market Research Report
By Type
Methadone, Fentanyl, Meperidine, Hydrocodone, Oxymorphone, Oxycodone
By Application
Pain Management, De-addiction
By Companies
Purdue Pharma, Pfizer, Janssen Pharmaceuticals, Teva Pharmaceuticals, Endo International, West-Ward Pharmaceuticals, Mallinckrodt Pharmaceuticals, Mylan, Impax Laboratories, Indivior
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Synthetic Opioids Market Report Segments:
The global Synthetic Opioids market is segmented on the basis of:
Types
Methadone, Fentanyl, Meperidine, Hydrocodone, Oxymorphone, Oxycodone
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pain Management, De-addiction
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Purdue Pharma
- Pfizer
- Janssen Pharmaceuticals
- Teva Pharmaceuticals
- Endo International
- West-Ward Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Mylan
- Impax Laboratories
- Indivior
Highlights of The Synthetic Opioids Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Methadone
- Fentanyl
- Meperidine
- Hydrocodone
- Oxymorphone
- Oxycodone
- By Application:
- Pain Management
- De-addiction
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Synthetic Opioids Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Synthetic opioids are a type of opioid that is not derived from opium. They are made in laboratories and can be more potent than traditional opioids.
Some of the key players operating in the synthetic opioids market are Purdue Pharma, Pfizer, Janssen Pharmaceuticals, Teva Pharmaceuticals, Endo International, West-Ward Pharmaceuticals, Mallinckrodt Pharmaceuticals, Mylan, Impax Laboratories, Indivior.
The synthetic opioids market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Synthetic Opioids Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Synthetic Opioids Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Synthetic Opioids Market - Supply Chain
4.5. Global Synthetic Opioids Market Forecast
4.5.1. Synthetic Opioids Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Synthetic Opioids Market Size (000 Units) and Y-o-Y Growth
4.5.3. Synthetic Opioids Market Absolute $ Opportunity
5. Global Synthetic Opioids Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Synthetic Opioids Market Size and Volume Forecast by Type
5.3.1. Methadone
5.3.2. Fentanyl
5.3.3. Meperidine
5.3.4. Hydrocodone
5.3.5. Oxymorphone
5.3.6. Oxycodone
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Synthetic Opioids Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Synthetic Opioids Market Size and Volume Forecast by Application
6.3.1. Pain Management
6.3.2. De-addiction
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Synthetic Opioids Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Synthetic Opioids Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Synthetic Opioids Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Synthetic Opioids Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Synthetic Opioids Demand Share Forecast, 2019-2026
9. North America Synthetic Opioids Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Synthetic Opioids Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Synthetic Opioids Market Size and Volume Forecast by Application
9.4.1. Pain Management
9.4.2. De-addiction
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Synthetic Opioids Market Size and Volume Forecast by Type
9.7.1. Methadone
9.7.2. Fentanyl
9.7.3. Meperidine
9.7.4. Hydrocodone
9.7.5. Oxymorphone
9.7.6. Oxycodone
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Synthetic Opioids Demand Share Forecast, 2019-2026
10. Latin America Synthetic Opioids Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Synthetic Opioids Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Synthetic Opioids Market Size and Volume Forecast by Application
10.4.1. Pain Management
10.4.2. De-addiction
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Synthetic Opioids Market Size and Volume Forecast by Type
10.7.1. Methadone
10.7.2. Fentanyl
10.7.3. Meperidine
10.7.4. Hydrocodone
10.7.5. Oxymorphone
10.7.6. Oxycodone
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Synthetic Opioids Demand Share Forecast, 2019-2026
11. Europe Synthetic Opioids Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Synthetic Opioids Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Synthetic Opioids Market Size and Volume Forecast by Application
11.4.1. Pain Management
11.4.2. De-addiction
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Synthetic Opioids Market Size and Volume Forecast by Type
11.7.1. Methadone
11.7.2. Fentanyl
11.7.3. Meperidine
11.7.4. Hydrocodone
11.7.5. Oxymorphone
11.7.6. Oxycodone
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Synthetic Opioids Demand Share, 2019-2026
12. Asia Pacific Synthetic Opioids Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Synthetic Opioids Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Synthetic Opioids Market Size and Volume Forecast by Application
12.4.1. Pain Management
12.4.2. De-addiction
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Synthetic Opioids Market Size and Volume Forecast by Type
12.7.1. Methadone
12.7.2. Fentanyl
12.7.3. Meperidine
12.7.4. Hydrocodone
12.7.5. Oxymorphone
12.7.6. Oxycodone
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Synthetic Opioids Demand Share, 2019-2026
13. Middle East & Africa Synthetic Opioids Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Synthetic Opioids Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Synthetic Opioids Market Size and Volume Forecast by Application
13.4.1. Pain Management
13.4.2. De-addiction
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Synthetic Opioids Market Size and Volume Forecast by Type
13.7.1. Methadone
13.7.2. Fentanyl
13.7.3. Meperidine
13.7.4. Hydrocodone
13.7.5. Oxymorphone
13.7.6. Oxycodone
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Synthetic Opioids Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Synthetic Opioids Market: Market Share Analysis
14.2. Synthetic Opioids Distributors and Customers
14.3. Synthetic Opioids Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Purdue Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Janssen Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teva Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Endo International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. West-Ward Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mallinckrodt Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mylan
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Impax Laboratories
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Indivior
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook